22.55 -0.46 (-2.00%)
TLCR
Stock Details
Last Trade:22.55 Change:-0.46 (-2.00%) Prev Close:23.01 Open: 22.99 Days Range:22.45 – 23.23 52 Week Range: 18.01 - 24.41 Volume:165597 P/E: N/AEPS:-0.05
View AllRecent Alerts 02/08/10
Recent Alert on 02/05/10 at 1:29pm
Talecris Biotherapeutics (TLCR) Granted Orphan Drug Designation by FDA for Alpha1-Proteinase Aersol Formula
Talecris Biotherapeutics (TLCR) Granted Orphan Drug Designation by FDA for Alpha1-Proteinase Aersol Formula
Talecris Biotherapeutics, Inc. (NASDAQ: TLCR) announced today that it was granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the development of an aerosol formulation of Alpha1-Proteinase Inhibitor (Human, A1PI) to... Read More
Recent Alert on 02/05/10 at 1:29pm
Talecris Biotherapeutics (TLCR) Granted Orphan Drug Designation by FDA for Alpha1-Proteinase Aersol Formula
Talecris Biotherapeutics (TLCR) Granted Orphan Drug Designation by FDA for Alpha1-Proteinase Aersol Formula
Recent Alert on 02/03/10 at 8:50am
CapStone Initiates Coverage on Talecris Biotherapeutics (TLCR) with a Buy; Unique Play in Pure Plasma Therapeutics
CapStone Initiates Coverage on Talecris Biotherapeutics (TLCR) with a Buy; Unique Play in Pure Plasma Therapeutics
Recent Alert on 11/11/09 at 8:26am
Barclays Initiates Coverage on Talecris Biotherapeutics (TLCR) with an Equalweight
Barclays Initiates Coverage on Talecris Biotherapeutics (TLCR) with an Equalweight
View AllRecent Press Releases
Press Release on 02/05/10 at 1:27pm
Talecris Biotherapeutics Receives Orphan Drug Designation for Aerosolized Alpha1-Proteinase Inhibitor to Treat Alpha1-Antitrypsin Deficiency
Talecris Biotherapeutics Receives Orphan Drug Designation for Aerosolized Alpha1-Proteinase Inhibitor to Treat Alpha1-Antitrypsin Deficiency
View AllRecent SEC Filings
SEC Filing on 02/05/10 at 1:25pm
Form SC 13G Talecris Biotherapeutics Filed by: LAZARD ASSET MANAGEMENT LLC
Form SC 13G Talecris Biotherapeutics Filed by: LAZARD ASSET MANAGEMENT LLC